Helsinn, the Swiss pharmaceutical Group focused on
building quality cancer care, is pleased to announce that William Mann, President and Chief
Executive Officer of Helsinn’s U.S. subsidiary, Helsinn Therapeutics (U.S.) Inc., will present at
the UBS Healthcare Conference at the Grand Hyatt in New York City. His overview of the
Helsinn Group will include an update on Helsinn’s U.S. business and will take place on Monday
23rd May at 10:30am EDT.

2016-05-23– Helsinn to Present at UBS Healthcare Conference in New York